AG-13958
目录号: A21175
VEGFR 抑制剂
AG-13958（AG-013958），一种强效的VEGFR酪氨酸激酶抑制剂，用于治疗与年龄相关的黄斑变性（AMD）相关的脉络膜新生血管化。
顾客使用 Adooq 产品发表的高质量科研文献
生物活性
| Discription | AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD). | ||
|---|---|---|---|
| Targets |
|
产品信息
| 目录号 | A21175 |
|---|---|
| 分子式 | C26H22FN7O |
| 分子量 | 467.5 |
| CAS号 | 319460-94-1 |
| SMILES | O=C(C1=CC(C)=NN1C)NC2=CC(NC3=CC4=C(C=C3)C(/C=C/C5=NC=CC=C5)=NN4)=CC=C2F |
| 其他名称 | AG 13958, AG13958, AG-013958, AG 013958, AG013958 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
| In vitro | DMSO | 91 mg/mL (194.64 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
Preparing Stock Solutions
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 21.39 mL | 106.95 mL | 213.9 mL |
| 0.5 mM | 4.28 mL | 21.39 mL | 42.78 mL |
| 1 mM | 2.14 mL | 10.7 mL | 21.39 mL |
| 5 mM | 0.43 mL | 2.14 mL | 4.28 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 AG-13958 | AG-13958 供应商 | AG-13958 花费 | AG-13958 生产商 | 订购 AG-13958 | AG-13958 代理商
| 购买 319460-94-1 | 319460-94-1 供应商 | 319460-94-1 花费 | 319460-94-1 生产商 | 订购 319460-94-1 | 319460-94-1 代理商